Oncology Clinical Trials in Newnan, GA
As of August 2026, 27 paid clinical trials are recruiting for Oncology in Newnan, Georgia. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
27 clinical trials for Oncology
·Clear filters·A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Top Research Study Locations in Newnan
Researchers run research studies in Newnan, GA at 22 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| CTCA at Southeastern Regional Medical Center | Advanced Lung Non-Small Cell Carcinoma, Extensive Stage Lung Small Cell Carcinoma, Locally Advanced Cervical Adenocarcinoma | 8 |
| City of Hope Atlanta Cancer Center | Advanced Colon Adenocarcinoma, Advanced Colorectal Adenocarcinoma, Advanced Rectal Adenocarcinoma | 7 |
| Southeastern Regional Medical Center | Follicular Lymphoma, B-cell Malignancy, Chronic Lymphocytic Leukemia | 4 |
| City of Hope Atlanta | Extensive Stage Small-cell Lung Cancer, Hodgkin Lymphoma, Lymphoma | 3 |
| City of Hope National Medical Center, Atlanta Cancer Center | Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chronic Lymphocytic Leukemia | 3 |
| Piedmont Newnan Hospital | Breast Cancer, Grade 2 Meningioma, Intracranial Meningioma | 3 |
| Vista Clinical Research | Chronic Migraine Headache, Degenerative Conditions of the Lumbar Spine, Headache (Migraine) | 3 |
| City Of Hope - Atlanta | Small Cell Lung Cancer, Multiple Myeloma, Hematologic Malignancies | 3 |
| City of Hope Cancer Center | Carcinoma, Non-Small-Cell Lung, Multiple Myeloma | 2 |
| Southeastern Regional Medical Center, Inc. dba City of Hope Atlanta | Relapsed or Refractory Large B-cell Lymphoma, Triple Negative Breast Cancer | 2 |
| Ambros Clinical Trial Site | Complex Regional Pain Syndrome Type I | 1 |
| Cancer Treatment Ctrs of America At | Lumbar Spinal Stenosis | 1 |
| City of Hope - Cancer Center Atlanta | Breast Cancer | 1 |
| City of Hope 1 | Carcinoma, Non-small-Cell Lung | 1 |
| City of Hope Cancer Center - Atlanta | Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms, Triple Negative Breast Neoplasms | 1 |
| City of Hope at Georgia - Atlanta | Lung Carcinoma | 1 |
| City of Hope® Atlanta | KRAS G12C Lung Cancer, Non-Small Cell Lung Cancer | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Georgia Bone and Joint | Shoulder Arthroplasty | 1 |
| Georgia Pain and Spine Care | Lumbar Spinal Stenosis | 1 |
| Newnan Surgery Center | Lumbar Spinal Stenosis | 1 |
| Vista Clinical Research/Summit Spine & Joint Centers | Osteoarthritic Knee Pain | 1 |
Active & Upcoming Studies in Newnan (2026)
Recruiting trials in Newnan grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (41 active studies)
- Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 · Phase 2 · City of Hope Medical Center
- Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial · Phase 3 · City of Hope Medical Center
Neurology & pain (3 active studies)
- A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine · Salvia BioElectronics
- Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE) · Phase 3 · Ambros Therapeutics, Inc.
Common conditions studied in Newnan
- Chronic Lymphocytic Leukemia (3 active studies)
- Multiple Myeloma (3 active studies)
- Small Lymphocytic Lymphoma (3 active studies)
- Breast Cancer (2 active studies)
- Breast Neoplasms (2 active studies)
- Carcinoma, Non-Small-Cell Lung (2 active studies)
Leading research sponsors in Newnan
- City of Hope Medical Center
- NRG Oncology
- National Cancer Institute (NCI)
- Amgen
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Newnan?
There are approximately 52 recruiting clinical trials in Newnan, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Newnan pay participants?
Most recruiting trials in Newnan compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Newnan?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Newnan?
The most common conditions under active study in Newnan include Chronic Lymphocytic Leukemia (3), Multiple Myeloma (3), Small Lymphocytic Lymphoma (3), Breast Cancer (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Newnan?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Newnan on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Newnan?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Newnan?
Recruiting research sites in Newnan include CTCA at Southeastern Regional Medical Center, City of Hope Atlanta Cancer Center, Southeastern Regional Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Newnan right now?
The largest active categories in Newnan are Cancer & tumors (41), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.